Cytokinetics Inc. buy Citigroup Inc.
Start price
22.12.25
/
50%
€55.50
Target price
22.12.26
-
Performance (%)
-3.60%
Price
26.02.26
€53.50
Summary
This prediction is currently active. With a performance of -3.60%, the BUY prediction for Cytokinetics Inc. by Citigroup_Inc_ is down slightly. This prediction currently runs until 22.12.26. The prediction end date can be changed by Citigroup_Inc_ at any time. Citigroup_Inc_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Cytokinetics Inc. | -7.759% | -7.759% |
| iShares Core DAX® | -0.383% | 1.093% |
| iShares Nasdaq 100 | -0.411% | -1.973% |
| iShares Nikkei 225® | 1.838% | 10.261% |
| iShares S&P 500 | -0.712% | 0.445% |
Comments by Citigroup_Inc_ for this prediction
In the thread Discuss Cytokinetics Inc.
Cytokinetics (NASDAQ:CYTK) had its "outperform" rating reaffirmed by analysts at Citigroup Inc..
Ratings data for CYTK provided by MarketBeat
Stopped prediction by Citigroup_Inc_ for Cytokinetics Inc.
Cytokinetics Inc.
Start price
Target price
Perf. (%)
€41.80
02.09.25
02.09.25
€71.78
02.09.26
02.09.26
27.99%
26.02.26
26.02.26
Cytokinetics Inc.
Start price
Target price
Perf. (%)
€29.40
07.05.25
07.05.25
€70.52
07.05.26
07.05.26
81.97%
26.02.26
26.02.26
Cytokinetics Inc.
Start price
Target price
Perf. (%)
€43.80
07.02.25
07.02.25
€82.96
07.02.26
07.02.26
21.00%
08.02.26
08.02.26

